Given the lack of detectable expression of ERα and ERβ in most PCa in vitro models, it is hard to reconcile with previously published results that showed decreased proliferation and survival of these cell lines following treatments with various SERMs. The gene discussed is ESR2; the disease is posterior cortical atrophy.